论文部分内容阅读
把“分子诊断”技术推广到普罗大众的视野,进入他们的生活,让人们用可负担的价格体验精准、快速的诊断方法,而不会再贻误最佳治疗时机——这是李响创业希望实现的最终目标。2016年9月,卡尤迪生物科技(北京)有限公司(以下简称“卡尤迪”)通过产品发布会,全面展示了公司在个性化精准医疗方向的探索,并与周宏灏院士、崔玉涛医生以及各个行业知名专家展开探讨。卡尤迪创始人兼CEO李响展示了Mini8 Plus荧光定量PCR检测平台在快速现场分子诊断领域的广泛应用。通过简单的“一步法”免核酸提取分子检测,Mini8可实现对目的基因进行现场普及及快速检验,将传统需耗时4小时的检测缩短至90分钟,甚至30分钟。
Promote “molecular diagnosis ” technology to the general public’s vision, into their lives, so that people can experience accurate and rapid diagnostic methods at affordable prices, and will not be adversely affected by the best treatment time - this is Li Xiang Venture Hope to achieve the ultimate goal. In September 2016, Cardouti Biotech (Beijing) Co., Ltd. (hereinafter referred to as “Card Eudemy”), through its product launches, fully demonstrated the company’s exploration in personalized and accurate medical treatment and held discussions with academician Zhou Honghao, Doctors and well-known experts in various industries to explore. Qiu Youdi founder and CEO Li Xiang demonstrated the Mini8 Plus fluorescence quantitative PCR detection platform in the field of rapid field diagnosis of a wide range of applications. With simple “one-step” nucleic acid-free molecular detection, the Mini8 enables on-the-spot popularity and rapid testing of the gene of interest, shortening the traditional four-hour test to 90 minutes or even 30 minutes.